Trulieve Cannabis Corp. (NYSE:TRLV) Sees Significant Decrease in Short Interest

Trulieve Cannabis Corp. (NYSE:TRLV – Get Free Report) was the target of a significant decrease in short interest in the month of October. As of October 30th, there was short interest totaling 3,841,922 shares, a decrease of 47.1% from the October 15th total of 7,259,177 shares. Currently, 2.1% of the company’s stock are sold short. Based on an average daily volume of 1,140,524 shares, the days-to-cover ratio is presently 3.4 days.

Trulieve Cannabis Stock Performance

TRLV traded down $0.55 on Monday, reaching $10.36. 1,855,359 shares of the company traded hands, compared to its average volume of 1,349,505. Trulieve Cannabis has a 52-week low of $4.62 and a 52-week high of $13.28. The business has a 50 day moving average price of $11.10. The company has a debt-to-equity ratio of 0.45, a quick ratio of 3.65 and a current ratio of 5.52.

Trulieve Cannabis (NYSE:TRLV – Get Free Report) last announced its quarterly earnings results on Thursday, November 5th. The company reported $0.09 EPS for the quarter, meeting the consensus estimate of $0.09. The business had revenue of $230.20 million during the quarter, compared to analysts’ expectations of $221.79 million. Trulieve Cannabis had a negative return on equity of 0.34% and a negative net margin of 41.22%. Research analysts expect that Trulieve Cannabis will post 0.13 EPS for the current fiscal year.

Institutional Trading of Trulieve Cannabis

Several hedge funds have recently added to or reduced their stakes in TRLV. Marshall Wace LLP bought a new position in shares of Trulieve Cannabis during the 3rd quarter worth about $18,722,000. State Street Corp bought a new position in Trulieve Cannabis during the third quarter valued at about $8,878,000. Jump Financial LLC bought a new position in Trulieve Cannabis during the third quarter valued at about $1,992,000. HighTower Advisors LLC bought a new position in Trulieve Cannabis during the third quarter valued at about $1,530,000. Finally, Landscape Capital Management L.L.C. acquired a new position in Trulieve Cannabis in the 3rd quarter valued at approximately $1,164,000.

Analysts Set New Price Targets

Several analysts recently weighed in on the company. Wall Street Zen lowered Trulieve Cannabis from a “buy” rating to a “hold” rating in a report on Saturday, August 8th. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $15.00 target price on shares of Trulieve Cannabis in a report on Monday, November 2nd. Finally, Weiss Ratings reiterated a “sell (d-)” rating on shares of Trulieve Cannabis in a research report on Friday, September 11th. One research analyst has rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Hold” and a consensus price target of $15.00.

Get Our Latest Report on Trulieve Cannabis

About Trulieve Cannabis

(Get Free Report)

Trulieve Cannabis Corp. is a U.S. cannabis company that cultivates, processes and sells cannabis products through a vertically integrated business. Its offerings include flower, concentrates, vape products, edibles and other cannabis products, sold under brands such as Trulieve and Modern Flower. Founded in Florida in 2015, the company built its business in that state and expanded into other U.S. markets, including Arizona and Pennsylvania. Its operations and product offerings are shaped by the regulations in each state where it operates.

Further Reading

Receive News & Ratings for Trulieve Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trulieve Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.